Tiny Zymeworks Snags $1.4B+ R&D Deal With Drug Giant Johnson & Johnson Post author:Sam Post published:November 12, 2017 Post category:BioPharma There’s nothing like a billion-plus dollar deal to make investors happy on a Monday. Source: BioSpace You Might Also Like GlaxoSmithKline is Eyeing Pfizer's $15B+ Consumer Biz January 9, 2018 Incoming Novartis CEO, Bayer Leader Join President Trump for Private Dinner at Davos January 25, 2018 Merck & Co. Becomes Victim of Massive Ransomware Cyber Attack June 27, 2017
Incoming Novartis CEO, Bayer Leader Join President Trump for Private Dinner at Davos January 25, 2018